DBBS to mark 35th anniversary, 1,000th graduate
The Division of Biology and Biomedical Sciences will mark two milestones May 1-2: its 35th anniversary and graduating its 1,000th student.
Deadly genetic disease stopped before zebrafish birth
School of Medicine research could lead to the prevention up to one-fifth of birth defects in humans caused by genetic mutations.
Drug prevents abnormalities that lead to seizures
School of Medicine scientists have used a drug to prevent the brain abnormalities that lead to seizures in mice with an inherited form of epilepsy.
Environment influences when drinking begins; genes’ role increases in transition to alcohol dependence
The influence of genetics increases as young women transition from their first drink to alcohol dependence. A team of researchers at the School of Medicine found that although environment is most influential in determining when drinking begins, genes play a larger role in advancing to problem drinking and alcohol dependence.
Many African-Americans have a gene that prolongs life after heart failure
About 40 percent of African-Americans have a genetic variant that can protect them after heart failure and prolong their lives, according to research conducted at the School of Medicine and collaborating institutions. The genetic variant has an effect that resembles that of beta blockers, drugs widely prescribed for heart failure. The new study offers a reason why beta blockers don’t appear to benefit some African-Americans.
Readily available treatment could help prevent heart disease in kidney patients
The estimated 19 million Americans living with chronic kidney disease (CKD) face a high risk of death from cardiovascular disease, usually related to high levels of blood phosphate. Now researchers at the School of Medicine have demonstrated that high blood phosphate directly stimulates calcification of blood vessels and that phosphate-binding drugs can decrease vascular calcification.
Washington University in St. Louis and AstraZeneca announce Alzheimer’s research collaboration
The School of Medicine and the pharmaceutical company AstraZeneca (NYSE:AZN) have announced a research collaboration that aims to develop new and improved ways to diagnose and treat Alzheimer’s disease. The major focus of the alliance will be biomarkers, characteristic changes in the brain and spinal fluid that physicians can use to diagnose Alzheimer’s disease and track its response to treatment.
Nano-sized technology has super-sized effect on tumors
School of Medicine researchers have used nanotechology to focus a much lower drug dose to slow tumor growth in rabbits.
New genetic links to psoriasis uncovered
School of Medicine researchers have discovered seven new sites of common DNA variation that increase the risk of psoriasis.
Brain network in children less complex than in adults
A brain network linked to introspective tasks is less intricate and well connected in children, School of Medicine scientists have learned.
View More Stories